Akanda Corp (AKAN)
2.35
0.00 (0.00%)
USD |
NASDAQ |
Jun 27, 10:25
Akanda Total Liabilities (Quarterly): 12.67M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.67M |
| June 30, 2023 | 14.86M |
| December 31, 2022 | 12.10M |
| June 30, 2022 | 8.842M |
| Date | Value |
|---|---|
| December 31, 2021 | 10.25M |
| September 30, 2021 | 6.710M |
| December 31, 2020 | 9.307M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.710M
Minimum
Sep 2021
14.86M
Maximum
Jun 2023
10.68M
Average
10.25M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 233.64M |
| Biodexa Pharmaceuticals Plc | 7.470M |
| Verona Pharma PLC | 64.92M |
| NuCana PLC | 18.52M |
| Autolus Therapeutics PLC | 319.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.84M |
| Shareholders Equity (Quarterly) | -3.829M |
| Debt to Equity Ratio | -1.009 |
| Current Ratio | 0.1775 |
| Net Debt Paydown Yield | -0.41% |